Palle Christophersen
Fundador en SANA AB .
Fortuna: 145 021 $ al 30/04/2024
Cargos activos de Palle Christophersen
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SANA AB | Director Técnico/Científico/I+D | 01/01/2014 | - |
Fundador | 01/01/2011 | - | |
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders. | Director Técnico/Científico/I+D | - | - |
Historial de carrera de Palle Christophersen
Antiguos cargos conocidos de Palle Christophersen.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
NTG NORDIC TRANSPORT GROUP A/S | Corporate Officer/Principal | 28/05/2010 | 01/01/2012 |
Formación de Palle Christophersen.
University of Copenhagen | Doctorate Degree |
Estadísticas
Internacional
Dinamarca | 5 |
Operativa
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Founder | 1 |
Sectorial
Transportation | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
NTG NORDIC TRANSPORT GROUP A/S | Transportation |
SANA AB | Health Technology |
Empresas privadas | 1 |
---|---|
Saniona A/S
Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders. | Commercial Services |
- Bolsa de valores
- Insiders
- Palle Christophersen
- Experiencia